ESBL, MBL and Ampc Lactamases Producing Superbugs – Havoc in the Intensive Care Units of Punjab India | Zendy

Loveena Oberoi | Zendy; Nachhatarjit Singh | Zendy; Poonam Sharma | Zendy; Aruna Aggarwal | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

ESBL, MBL and Ampc Lactamases Producing Superbugs – Havoc in the Intensive Care Units of Punjab India

Author(s) -

Loveena Oberoi,

Nachhatarjit Singh,

Poonam Sharma,

Aruna Aggarwal

Publication year - 2013

Publication title -

journal of clinical and diagnostic research

Language(s) - English

Resource type - Journals

eISSN - 2249-782X

pISSN - 0973-709X

DOI - 10.7860/jcdr/2012/5016.2673

Subject(s) - antibiotic resistance , microbiology and biotechnology , klebsiella pneumonia , multiple drug resistance , antibiotics , intensive care , antimicrobial , escherichia coli , biology , drug resistance , medicine , intensive care medicine , biochemistry , gene

An alarming rise in the rates of the antibiotic resistance has now become a serious and an increasingly common public health concern, with severe implications, especially in the intensive care units. A variety of β-lactamases which include ESBLs, AmpC β-lactamases and metallo-βlactamases, have emerged as the most worrisome mechanism of resistance among the gram negative bacteria, which pose a therapeutic challenge to the health care settings.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research